Connect with us
[bsa_pro_ad_space id=12]

Business

Trump eyes ‘reciprocal’ trade deals over flat fee tariffs

Published

3 minute read

From The Center Square

By 

“We’re going to have tariffs, mostly reciprocal tariffs … probably reciprocal tariffs where a country pays so much or charges us so much and we do the same, so very reciprocal because I think that’s the only fair way to do it. That way no one is hurt. They charge us, we charge them”

President Donald Trump said Friday he was considering reciprocal trade deals with countries rather than flat fee tariffs on imported goods from other countries.

Trump touted tariffs throughout his campaign and during his inauguration said tariff revenue would make the U.S. “rich as hell.” He also said that tariff revenue would lower the tax burden on American taxpayers.

On Friday, the president said he would announce reciprocal trade agreements next week with multiple countries. His remarks came during a news conference with Japan Prime Minister Shigeru Ishiba.

“The United States will be conducting trade with all countries based on the principle of fairness and reciprocity,” Trump said.

The president said that chronic trade deficits undermine the U.S. economy.

“We’re going to have tariffs, mostly reciprocal tariffs … probably reciprocal tariffs where a country pays so much or charges us so much and we do the same, so very reciprocal because I think that’s the only fair way to do it. That way no one is hurt. They charge us, we charge them,” Trump said.

Trump said the reciprocal trade deals seem to be the path forward rather than flat fee tariffs. He said he would be announcing trade deals as early as Monday or Tuesday.

On Feb. 1, Trump hit Mexico and Canada with 25% tariffs and levied an additional 10% tariff on China. Two days later, Trump suspended tariffs on the U.S. neighbors for 30 days after reaching preliminary deals with both Mexico and Canada. The leaders of both neighboring countries promised to strengthen border security. China responded with limited tariffs on U.S. goods and filed a complaint about Trump’s unilateral trade move with the World Trade Organization.

Most economists have panned Trump’s tariff plans. On Thursday, S&P Global, a credit-rating agency, reported the potential effects of Trump’s tariffs were “overwhelmingly negative.” S&P analysts said the tariffs could slow gross domestic product growth, boost unemployment and inflation. It noted that “the effects on the U.S. are smaller than for trading partners.” Gross domestic product, or GDP, is a measure of economic output. S&P noted the uncertainty around Trump’s tariff plans creates problems for businesses and U.S. families.

“Uncertainty around the path of U.S. policy and its objectives is high, and confidence bands around our forecasts are correspondingly wide,” according to the S&P report. “Moreover, the ongoing deal-making mode of the new administration risks complicating long-term decision making by both firms and households.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Exposing Global Affairs Canada’s crazy spending spree

Published on

From the Canadian Taxpayers Association

By Franco Terrazzano

$1,700 on Lesbian Pirates! musical $3,900 for a “frank discussion” of “how to do a proper land acknowledgment” Millions on vacant land in Africa and properties in Afghanistan we abandoned to the Taliban $7,500 to promote DEI at music festival in Estonia $12,000 so seniors in other countries could talk about their sex lives $7.2 million for “gender-responsive systems approach to universal healthcare in the Philippines” $13,000 for an Oscars party in LA $8,800 for a show called “whose jizz is this” And so much more…

Continue Reading

Addictions

Calls for Public Inquiry Into BC Health Ministry Opioid Dealing Corruption

Published on

Sam Cooper

The leaked audit shows from 2022 to 2024, a staggering 22,418,000 doses of opioids were prescribed by doctors and pharmacists to approximately 5,000 clients in B.C., including fentanyl patches.

A confidential investigation by British Columbia’s Ministry of Health, Financial Operations and Audit Branch has uncovered explosive allegations of fraud, abuse, and organized crime infiltration within PharmaCare’s prescribed opioid alternatives program. Internal audit findings, obtained by The Bureau, suggest that millions of taxpayer dollars are being diverted into illicit drug trafficking networks rather than serving harm reduction efforts.

The leaked documents include photographs from vehicle searches that show collections of fentanyl patches and Dilaudid (hydromorphone) apparently packaged for resale after being stolen from the taxpayer-funded “safer supply” program. This program expanded dramatically following a federal law change implemented by Prime Minister Justin Trudeau’s government in 2020, which broadened circumstances in which pharmacy staff could dispense opioids, according to the document’s evidence.

“Prior to March 17, 2020, only pharmacists in BC were permitted to deliver [addiction therapy treatment] drugs,” the audit says.

B.C.’s safer supply program was launched in March 2020 as a response to the opioid overdose crisis, declared in 2016. It allows people with opioid-use disorder to receive prescribed drugs to be used on-site or taken away for later use.

The Special Investigations Unit and PharmaCare Audit Intelligence team identified a disturbing link between doctors, pharmacists, assisted living residences, and organized crime, where prescription opioids meant to replace illicit drugs are instead being diverted, sold, and trafficked at scale.

“A significant portion of the opioids being freely prescribed by doctors and pharmacists are not being consumed by their intended recipients,” the document states.

It suggests that financial incentives have created a business model for organized crime, asserting that “prescribed alternatives (safe supply opioids) are trafficked provincially, nationally, and internationally,” and that “proceeds of fraud” are being used to pay incentives to doctors, pharmacists, and intermediaries.

BC Conservative critic Elenore Sturko, a former RCMP officer, began raising concerns about the program two years ago after hearing anecdotes about prescribed opioids being trafficked. She asserts that the program is a failure in public policy and insists that Provincial Health Officer Dr. Bonnie Henry be dismissed for having “denied and downplayed” problems as they emerged. Sturko also argues that B.C. must change its drug policy in light of U.S. President Donald Trump’s stance linking the trafficking of fentanyl and other opioids to potential trade sanctions against Canada.

The document shows that PharmaCare’s dispensing fee loophole has incentivized pharmacies to maximize billings per patient, with some locations charging up to $11,000 per patient per year—compared to just $120 in normal cases.

Perhaps most alarming is the deep infiltration of B.C.’s safer supply program by criminal networks. The Ministry of Health report lists “Gang Members/Organized Crime” as key players in the prescription drug pipeline, which includes “Doctors, pharmacies, and assisted living residences.”

This revelation confirms long-standing fears that B.C.’s “safe supply” policy—originally designed to prevent deaths from contaminated street drugs—is instead sometimes supplying criminal organizations with pharmaceutical-grade opioids.

The leaked audit shows from 2022 to 2024, a staggering 22,418,000 doses of opioids were prescribed by doctors and pharmacists to approximately 5,000 clients in B.C., including fentanyl patches.

Beyond organized crime’s direct involvement, pharmacies themselves have exploited regulatory gaps to generate massive profits from PharmaCare’s policies:

  • Pharmacies offer kickbacks to doctors, housing staff, and medical professionals to steer patients toward specific locations.
  • Financial incentives fuel fraud, with multiple investigations identifying 60+ pharmacies offering incentives to clients.
  • Non-health professionals, including housing staff, are witnessing OAT (opioid agonist treatment) dosing, violating patient safety protocols.

The Bureau is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

For the full experience, please upgrade your subscription and support a public interest startup. We break international stories and this requires elite expertise, time and legal costs.

Continue Reading

Trending

X